258 related articles for article (PubMed ID: 12690492)
1. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.
Bolt HM; Roos PH; Thier R
Int Arch Occup Environ Health; 2003 Apr; 76(3):174-85. PubMed ID: 12690492
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene].
Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810
[TBL] [Abstract][Full Text] [Related]
3. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
4. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments.
Lucas D; Ferrara R; Gonzales E; Albores A; Manno M; Berthou F
Toxicol Lett; 2001 Oct; 124(1-3):71-81. PubMed ID: 11684359
[TBL] [Abstract][Full Text] [Related]
6. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations.
Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W
Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype.
Carrière V; Berthou F; Baird S; Belloc C; Beaune P; de Waziers I
Pharmacogenetics; 1996 Jun; 6(3):203-11. PubMed ID: 8807659
[TBL] [Abstract][Full Text] [Related]
8. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.
Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D
Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk.
Kato S; Shields PG; Caporaso NE; Hoover RN; Trump BF; Sugimura H; Weston A; Harris CC
Cancer Res; 1992 Dec; 52(23):6712-5. PubMed ID: 1423319
[TBL] [Abstract][Full Text] [Related]
10. Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene.
Inoue K; Yamazaki H; Shimada T
Arch Toxicol; 2000 Sep; 74(7):372-8. PubMed ID: 11043492
[TBL] [Abstract][Full Text] [Related]
11. Interest of genotyping and phenotyping of drug-metabolizing enzymes for the interpretation of biological monitoring of exposure to styrene.
Haufroid V; Jakubowski M; Janasik B; Ligocka D; Buchet JP; Bergamaschi E; Manini P; Mutti A; Ghittori S; Arand M; Hangen N; Oesch F; Hirvonen A; Lison D
Pharmacogenetics; 2002 Dec; 12(9):691-702. PubMed ID: 12464798
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
13. Possible impact of human CYP2E1 polymorphisms on the metabolism of acrylonitrile.
Thier R; Lewalter J; Selinski S; Bolt HM
Toxicol Lett; 2002 Mar; 128(1-3):249-55. PubMed ID: 11869835
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene.
Haufroid V; Buchet JP; Gardinal S; Lison D
Int Arch Occup Environ Health; 2002 Sep; 75(7):453-8. PubMed ID: 12172891
[TBL] [Abstract][Full Text] [Related]
15. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.
Ulusoy G; Arinç E; Adali O
Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320
[TBL] [Abstract][Full Text] [Related]
16. Use of the CYP2E1 genotype and phenotype for the biological monitoring of occupational exposure to styrene.
Prieto-Castelló MJ; Cardona A; Marhuenda D; Roel JM; Corno A
Toxicol Lett; 2010 Jan; 192(1):34-9. PubMed ID: 20117323
[TBL] [Abstract][Full Text] [Related]
17. Evolution of camel CYP2E1 and its associated power of binding toxic industrial chemicals and drugs.
Kandeel M; Altaher A; Kitade Y; Abdelaziz M; Alnazawi M; Elshazli K
Comput Biol Chem; 2016 Oct; 64():271-280. PubMed ID: 27497234
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype.
Powell H; Kitteringham NR; Pirmohamed M; Smith DA; Park BK
Pharmacogenetics; 1998 Oct; 8(5):411-21. PubMed ID: 9825833
[TBL] [Abstract][Full Text] [Related]
19. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases.
Zgheib NK; Mitri Z; Geryess E; Noutsi P
Genet Test Mol Biomarkers; 2010 Jun; 14(3):393-7. PubMed ID: 20406102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
